I have always found the agency extremely professional and competent in the meetings that I have been involved in. I do not doubt that 2-73 will see approval based on the 2b/3 trial results. There is a non-zero chance that Anavex is overstating the strength of its data, but while non-zero I believe it is very very close to zero.